Arne Ostman

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Pan-cancer atlas of cellular architecture reveals a nearest-neighbour distance-associated biomechanical-immune axis involving CD4+ memory T cells.

Pan-cancer atlas of cellular architecture reveals a nearest-neighbour distance-associated biomechanical-immune axis involving CD4+ memory T cells.

Journal: Clinical and translational medicine

Published: April 30, 2026

Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis.

Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis.

Journal: Journal of translational medicine

Published: April 19, 2026

The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2- breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial.

The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2- breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial.

Journal: BMC medicine

Published: January 13, 2026

Tumor-Infiltrating mregDCs Restrain Anti-Tumor Immunity in Early Relapse HCC.

Tumor-Infiltrating mregDCs Restrain Anti-Tumor Immunity in Early Relapse HCC.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 28, 2025

Myogenic IGFBP5 levels in rhabdomyosarcoma are nourished by mesenchymal stromal cells and regulate growth arrest and apoptosis.

Myogenic IGFBP5 levels in rhabdomyosarcoma are nourished by mesenchymal stromal cells and regulate growth arrest and apoptosis.

Journal: Cell communication and signaling : CCS

Published: January 01, 2025

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density.

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density.

Journal: Gynecologic oncology

Published: August 13, 2024

Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.

Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.

Journal: Upsala journal of medical sciences

Published: April 14, 2024

Functional and clinical roles of stromal PDGF receptors in tumor biology.

Functional and clinical roles of stromal PDGF receptors in tumor biology.

Journal: Cancer metastasis reviews

Published: February 07, 2024

Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry.

Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry.

Journal: Frontiers in immunology

Published: October 20, 2023

Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment.

Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment.

Journal: Frontiers in immunology

Published: August 25, 2023

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation.

A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation.

Journal: mAbs

Published: June 19, 2023

Vessel size as a marker of survival in estrogen receptor positive breast cancer.

Vessel size as a marker of survival in estrogen receptor positive breast cancer.

Journal: Breast cancer research and treatment

Published: March 06, 2023

Showing 1-12 of 99

Last Updated: 09/26/2026